SEC Info - Loeb Daniel S, et al. - ‘SC 13D/A’ on 10/26/05 re: Ligand Pharmaceuticals Inc

SEC Info℠

Home

Help

Please Sign In

Loeb Daniel S, et al. – ‘SC 13D/A’ on 10/26/05 re: Ligand Pharmaceuticals Inc

On: Wednesday, 10/26/05, at 3:04pm ET · Accession #: 899140-5-962 · File #: 5-43329

  As Of                Filer                Filing    For·On·As Docs:Size              Issuer               Agent

10/26/05  Loeb Daniel S                     SC 13D/A               2:18K  Ligand Pharmaceuticals Inc        Willkie Fa… Gallagher/FA
          Third Point LLC
          Third Point Offshore Fund, Ltd.

Amendment to General Statement of Beneficial Ownership — Schedule 13D
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: SC 13D/A    Amendment No. 3                                        6     24K 
 2: EX-1        Letter to Shareholders                                 3     11K

SC 13D/A — Amendment No. 3
Document Table of Contents

Page	(sequential)	\|	(alphabetic)	Top
			Alternative Formats (Word, et al.) Material to be Filed as Exhibits Purpose of Transaction Schedule 13D
1	1st Page - Filing Submission
"	Schedule 13D
5	Item 4. Purpose of Transaction
"	Item 7. Material to be Filed as Exhibits

SC 13D/A 1st Page of 6 TOC ↑Top Previous Next ↓Bottom Just 1st
 
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13D
 (Amendment No. 3)

Under the Securities Exchange Act of 1934*

 Ligand Pharmaceuticals Incorporated
 -----------------------------------
(Name of Issuer)

Common Stock, par value $0.001 per share
----------------------------------------
(Title of Class of Securities)

 53220K207
 ---------
 (CUSIP Number of Class of Securities)

Daniel S. Loeb
 Third Point LLC
 390 Park Avenue
New York, NY 10022
(212) 224-7400
--------------
 (Name, Address and Telephone Number of Person
 Authorized to Receive Notices and Communications)

Copies to:
 Jack H. Nusbaum, Esq.
Willkie Farr & Gallagher LLP
787 Seventh Avenue
 New York, NY 10019-6099
(212) 728-8000

October 26, 2005
----------------
 (Date of Event which Requires
Filing of this Schedule)

If the filing person has previously filed a statement on Schedule 13G to report 
the acquisition which is the subject of this Schedule 13D, and is filing this   
schedule because of ss.ss. 240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the
following box: [ ]                                                              

NOTE: Schedules filed in paper format shall include a signed original and five  
copies of the schedule, including all exhibits. See Rule 240.13d-7 for other    
parties to whom copies are to be sent.                                          

* The remainder of this cover page shall be filled out for a reporting person's 
initial filing on this form with respect to the subject class of securities, and
for any subsequent amendment containing information which would alter           
disclosures provided in a prior cover page.                                     

The information required on the remainder of this cover page shall not be deemed
to be "filed" for the purpose of Section 18 of the Securities Exchange Act of   
1934 ("Act") or otherwise subject to the liabilities of that section of the Act 
but shall be subject to all other provisions of the Act (however, see the       
Notes).                                                                         

SC 13D/A 2nd Page of 6 TOC 1st Previous Next ↓Bottom Just 2nd
SCHEDULE 13D

-------------------                                           ------------------
CUSIP No. 53220K207                                           Page 2 of 10 Pages
-------------------                                           ------------------
----------- --------------------------------------------------------------------
1       NAME OF REPORTING PERSON                                        
   I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)

Daniel S. Loeb                                          
----------- --------------------------------------------------------------------
    2       CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP             (a) [ ]
                                                                         (b) [X]
----------- --------------------------------------------------------------------
3       SEC USE ONLY                                                    
----------- --------------------------------------------------------------------
4       SOURCE OF FUNDS*                                                

AF                                                      
----------- --------------------------------------------------------------------
   5       CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDING IS REQUIRED PURSUANT TO
ITEMS 2(d) or 2(e) [ ]                                  
----------- --------------------------------------------------------------------
6       CITIZENSHIP OR PLACE OF ORGANIZATION                            

United States                                           
--------------------- --------- ------------------------------------------------
7      SOLE VOTING POWER      

0               
    NUMBER OF         --------- ------------------------------------------------
SHARES              8      SHARED VOTING POWER                        
BENEFICIALLY                                                                
OWNED BY                    7,000,000                                   
      EACH            --------- ------------------------------------------------
REPORTING             9      SOLE DISPOSITIVE POWER                       
PERSON WITH                                                                 
0               
                      --------- ------------------------------------------------
 10     SHARED DISPOSITIVE POWER

7,000,000       
----------- --------------------------------------------------------------------
11      AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH PERSON              

7,000,000                                               
----------- --------------------------------------------------------------------
12      CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN  
SHARES* [ ]                                             
----------- --------------------------------------------------------------------
13      PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)              

9.47%                                                   
----------- --------------------------------------------------------------------
14      TYPE OF REPORTING PERSON*                                       

IN                                                      
----------- --------------------------------------------------------------------

SC 13D/A 3rd Page of 6 TOC 1st Previous Next ↓Bottom Just 3rd
SCHEDULE 13D

-------------------                                           ------------------
CUSIP No. 53220K207                                           Page 3 of 10 Pages
-------------------                                           ------------------
----------- --------------------------------------------------------------------
1       NAME OF REPORTING PERSON                                        
   I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)

Third Point LLC    I.D. #13-3922602                     
----------- --------------------------------------------------------------------
    2       CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP             (a) [ ]
                                                                         (b) [X]
----------- --------------------------------------------------------------------
3       SEC USE ONLY                                                    
----------- --------------------------------------------------------------------
4       SOURCE OF FUNDS*                                                

AF                                                      
----------- --------------------------------------------------------------------
   5       CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDING IS REQUIRED PURSUANT TO
ITEMS 2(d) or 2(e) [ ]                                  
----------- --------------------------------------------------------------------
6       CITIZENSHIP OR PLACE OF ORGANIZATION                            

Delaware                                                
--------------------- --------- ------------------------------------------------
7      SOLE VOTING POWER      

0               
    NUMBER OF         --------- ------------------------------------------------
SHARES              8      SHARED VOTING POWER                        
BENEFICIALLY                                                                
OWNED BY                    7,000,000                                   
      EACH            --------- ------------------------------------------------
REPORTING             9      SOLE DISPOSITIVE POWER                       
PERSON WITH                                                                 
0               
                      --------- ------------------------------------------------
 10     SHARED DISPOSITIVE POWER

7,000,000       
----------- --------------------------------------------------------------------
11      AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH PERSON              

7,000,000                                               
----------- --------------------------------------------------------------------
12      CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN  
SHARES* [ ]                                             
----------- --------------------------------------------------------------------
13      PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)              

9.47%                                                   
----------- --------------------------------------------------------------------
14      TYPE OF REPORTING PERSON*                                       

OO                                                      
----------- --------------------------------------------------------------------

SC 13D/A 4th Page of 6 TOC 1st Previous Next ↓Bottom Just 4th
SCHEDULE 13D

-------------------                                           ------------------
CUSIP No. 53220K207                                           Page 4 of 10 Pages
-------------------                                           ------------------
----------- --------------------------------------------------------------------
1       NAME OF REPORTING PERSON                                        
   I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)

Third Point Offshore Fund, Ltd.                         
----------- --------------------------------------------------------------------
    2       CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP             (a) [ ]
                                                                         (b) [X]
----------- --------------------------------------------------------------------
3       SEC USE ONLY                                                    
----------- --------------------------------------------------------------------
4       SOURCE OF FUNDS*                                                

AF                                                      
----------- --------------------------------------------------------------------
   5       CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDING IS REQUIRED PURSUANT TO
ITEMS 2(d) or 2(e) [ ]                                  
----------- --------------------------------------------------------------------
6       CITIZENSHIP OR PLACE OF ORGANIZATION                            

Cayman Islands                                          
--------------------- --------- ------------------------------------------------
7      SOLE VOTING POWER      

0               
    NUMBER OF         --------- ------------------------------------------------
SHARES              8      SHARED VOTING POWER                        
BENEFICIALLY                                                                
OWNED BY                    4,573,400                                   
      EACH            --------- ------------------------------------------------
REPORTING             9      SOLE DISPOSITIVE POWER                       
PERSON WITH                                                                 
0               
                      --------- ------------------------------------------------
 10     SHARED DISPOSITIVE POWER

4,573,400       
----------- --------------------------------------------------------------------
11      AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH PERSON              

4,573,400                                               
----------- --------------------------------------------------------------------
12      CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN  
SHARES* [ ]                                             
----------- --------------------------------------------------------------------
13      PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)              

6.19%                                                   
----------- --------------------------------------------------------------------
14      TYPE OF REPORTING PERSON*                                       

OO                                                      
----------- --------------------------------------------------------------------

SC 13D/A 5th Page of 6 TOC 1st Previous Next ↓Bottom Just 5th
 This Amendment No. 3 (the "Amendment") amends the Schedule 13D filed on
September 23, 2005 (together with amendments filed prior to the date hereof, the
"Schedule 13D"), and is being filed on behalf of Third Point LLC, a Delaware    
limited liability company (the "Management Company"), Third Point Offshore Fund,
Ltd., a Cayman Island limited liability exempted company (the "Offshore Fund"), 
and Daniel S. Loeb, an individual ("Mr. Loeb" and, together with the Management 
Company and the Offshore Fund, the "Reporting Persons"). This Schedule 13D      
relates to the common stock, par value $0.001 per share, of Ligand              
Pharmaceuticals Incorporated, a Delaware corporation (the "Company"). Unless the
context otherwise requires, references herein to the "Common Stock" are to such 
common stock of the Company. The Management Company is the investment manager or
adviser to a variety of hedge funds and managed accounts (such funds and        
accounts, collectively, including but not limited to the Offshore Fund, the     
"Funds"). The Funds directly own the Common Stock to which this Schedule 13D    
relates, and the Reporting Persons may be deemed to have beneficial ownership   
over such Common Stock by virtue of their ownership or the authority granted to 
them by the Funds to vote and to dispose of the securities held by the Funds,   
including the Common Stock.                                                     

Item 4.  Purpose of Transaction.                                                

Item 4 of the Schedule 13D is hereby amended by adding thereto the    
following:                                                                      

   In a letter, dated October 25, 2005, from Mr. Loeb, as managing member of
the Management Company, to the shareholders of the Company (a copy of which is  
attached hereto as Exhibit 1), Mr. Loeb indicated, among other things, that the 
Reporting Persons intend to file proxy materials with the SEC and to run either 
a full or partial slate of directors at the next shareholders meeting.          

Item 7.  Material to be Filed as Exhibits.                                      

   1. Letter from the Management Company to the shareholders of the Company.

5 

SC 13D/A Last Page of 6 TOC 1st Previous Next ↓Bottom Just 6th
SIGNATURES

   After reasonable inquiry and to the best of our knowledge and belief, the
undersigned certify that the information set forth in this statement is true,   
complete and correct.                                                           

Dated: October 26, 2005                                                         

               THIRD POINT LLC

                       By:  /s/ Daniel S. Loeb
                                            ------------------------------------
                             Name:  Daniel S. Loeb
                                       Title:  Chief Executive Officer

                               THIRD POINT OFFSHORE FUND, LTD.

                       By:  /s/ Daniel S. Loeb
                                            ------------------------------------
                             Name:  Daniel S. Loeb
                        Title:  Director

/s/ Daniel S. Loeb                      
        --------------------------------------------------
Daniel S. Loeb                            

[SIGNATURE PAGE TO AMENDMENT NO. 3 TO SCHEDULE 13D
 WITH RESPECT TO
LIGAND PHARMACEUTICALS INCORPORATED]

SC 13D/A	1st Page of 6	TOC	↑Top	Previous	Next	↓Bottom	Just 1st

SC 13D/A	2nd Page of 6	TOC	1st	Previous	Next	↓Bottom	Just 2nd

SC 13D/A	3rd Page of 6	TOC	1st	Previous	Next	↓Bottom	Just 3rd

SC 13D/A	4th Page of 6	TOC	1st	Previous	Next	↓Bottom	Just 4th

SC 13D/A	5th Page of 6	TOC	1st	Previous	Next	↓Bottom	Just 5th

SC 13D/A	Last Page of 6	TOC	1st	Previous	Next	↓Bottom	Just 6th

Dates Referenced Herein and Documents Incorporated by Reference

		Referenced-On Page
This ‘SC 13D/A’ Filing	Date	First	Last	Other Filings

Filed on:	10/26/05	1	6	DEFN14A
	10/25/05	5		DEFN14A
	9/23/05	5		SC 13D
				List all Filings

↑Top

Filing Submission 0000899140-05-000962 – Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Loeb Daniel S, et al. – ‘SC 13D/A’ on 10/26/05 re: Ligand Pharmaceuticals Inc

On: Wednesday, 10/26/05, at 3:04pm ET · Accession #: 899140-5-962 · File #: 5-43329

Previous ‘SC 13D’: ‘SC 13D/A’ on 10/12/05 · Next: ‘SC 13D/A’ on 3/16/06 · Latest: ‘SC 13D/A’ on 8/9/23

Amendment to General Statement of Beneficial Ownership — Schedule 13DFiling Table of Contents

SC 13D/A — Amendment No. 3Document Table of Contents

Dates Referenced Herein and Documents Incorporated by Reference

Amendment to General Statement of Beneficial Ownership — Schedule 13D
Filing Table of Contents

SC 13D/A — Amendment No. 3
Document Table of Contents